Unravelling the role of natural and synthetic products as DNA topoisomerase inhibitors in hepatocellular carcinoma.

Bioorg Chem

School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR 999077, China. Electronic address:

Published: December 2024

Topoisomerase is a ubiquitous enzyme in the control of DNA chain topology. There have been extensive research on topoisomerase inhibitors derived from natural sources, which act as partial inducers of tumor cell apoptosis. However, their specific efficacy in treating hepatocellular carcinoma is relatively unexplored. Hence, this comprehensive review focuses on the structural characteristics and anti-cancer properties of topoisomerase inhibitors in hepatocellular carcinoma. Furthermore, this review is also elucidating the mechanism of action, structure-activity relationships, therapeutic limitations, stage of clinical trials of described classes of natural bioactive compounds as well as their potential application in cancer chemotherapies. This broad understanding of topoisomerase medical biology will provide indispensable framework for enhancing the efficiency of rational anti-hepatocellular carcinoma drug discovery.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bioorg.2024.107860DOI Listing

Publication Analysis

Top Keywords

topoisomerase inhibitors
12
hepatocellular carcinoma
12
inhibitors hepatocellular
8
topoisomerase
5
unravelling role
4
role natural
4
natural synthetic
4
synthetic products
4
products dna
4
dna topoisomerase
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!